Trial
NCT02660528
Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
—
Condition
Major Depressive Disorder
Intervention
Tocilizumab
Why stopped
Study staff change.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-20